RecruitingNCT04596592

Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth

Sponsor

University of Colorado, Denver

Enrollment

90 participants

Start Date

Feb 15, 2021

Study Type

OBSERVATIONAL

Conditions

Gender Dysphoria Insulin Sensitivity Transgenderism

Summary

To evaluate the effect of estradiol with or without a prior gonadotropin releasing hormone analogue on insulin sensitivity and vascular function in transgender females compared to cisgender controls.

Eligibility

Min Age: 13 YearsMax Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with gender dysphoria, insulin sensitivity, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 13 Years to 16 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Children's Hospital Colorado

Aurora, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04596592

Related Trials

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

NCT061388212 locations

Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy

NCT071471661 location